BPC-157 appears to interact with the function of various growth factors, including vascular endothelial growth factor (VEGF)
Notably, acetyl-CoA synthetase 2 (ACSS2) has been identified as a lactoyltransferase that mediates lactylation and promotes tumor immune evasion [49]
In: The Exogenous Antioxidants
For the complete clinical picture of what BPC-157 is, how it works at the molecular level, and how we evaluate candidates at intake, our full guide to BPC-157 at Perfect B in Doral covers the molecular mechanism, the compounding and prescription process, and what the initial evaluation looks like
Each plan starts with evaluation, lab review, and provider guidance
If significant deficiency is confirmed via blood test, a loading dose protocol may be recommended in line with NICE guidance typically more frequent injections over the initial weeks to rapidly restore levels